In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Yield10 Bioscience Inc (YTEN). The company’s shares closed last Monday at $0.96.
According to TipRanks.com, Klieve is a 4-star analyst with an average return of 7.5% and a 47.4% success rate. Klieve covers the Consumer Goods sector, focusing on stocks such as AgroFresh Solutions Inc, Arcadia Biosciences, and S&W Seed Company.
Currently, the analyst consensus on Yield10 Bioscience Inc is a Strong Buy with an average price target of $2.50, which is a 152.5% upside from current levels. In a report issued on August 13, Aegis Capital also maintained a Buy rating on the stock with a $2 price target.
See today’s analyst top recommended stocks >>
Based on Yield10 Bioscience Inc’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $1.87 million. In comparison, last year the company had a GAAP net loss of $2.39 million.
Based on the recent corporate insider activity of 7 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of YTEN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.
